Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Barclays PLC
  6. News
  7. Summary
    BARC   GB0031348658

BARCLAYS PLC

(BARC)
  Report
Real-time Estimate Cboe Europe  -  05:58 2022-11-28 am EST
159.82 GBX   +0.48%
05:58aBarclays CEO To Work From Home After Starting Cancer Treatment
MT
05:36aBarclays CEO reveals cancer treatment but will continue to manage bank
AN
04:56aBarclays says CEO Venkatakrishnan to undergo cancer treatment
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Days
:
Hours
:
Minutes
:
Seconds

Barclays Resumes Further Issuances and Sales of Certain iPath« ETNs

09/26/2022 | 07:08am EST

Barclays Bank PLC (“Barclays Bank”) announced today that it is resuming further issuances and sales by Barclays Bank and its affiliates of each series of iPath® ETNs (the “ETNs”) listed in the table below, effective as of the open of trading today, September 26, 2022. This action follows the announcements by Barclays Bank on March 14, 2022, April 22, 2022 and April 28, 2022 to suspend sales of the ETNs. As Barclays Bank indicated in its announcement on August 1, 2022, further issuances and sales of the ETNs are being resumed now that the rescission offer has been completed and settlement of the rescission offer with respect to the ETNs has occurred. Further issuances and sales of the ETNs will be made pursuant to Barclays Bank’s shelf registration statement filed with the Securities and Exchange Commission (the “SEC”) on May 23, 2022. As described below, this action may result in fluctuations in the trading value of the ETNs.

Name of ETN

Ticker

Exchange

CUSIP

iPath® Series B S&P 500® VIX Short-Term FuturesTM ETN

VXX

CBOE BZX

06747R477

iPath® Pure Beta Crude Oil ETN

OIL

NYSE Arca

06740P221

Pacer® iPath® Gold Trendpilot ETN

PBUG

NYSE Arca

06747T382

iPath® Series B Bloomberg Natural Gas Subindex Total ReturnSM ETN

GAZ

NYSE Arca

06745T368

iPath® Series B Carbon ETN

GRN

NYSE Arca

06747C322

iPath® Series B Bloomberg Energy Subindex Total ReturnSM ETN

JJE

NYSE Arca

06746P530

The market value of the ETNs may be influenced by, among other things, the levels of supply and demand for such ETNs. Recently, a premium or discount, as the case may be, has developed in the trading price of certain series of ETNs in relation to the intraday indicative value of such series. It is possible that this reopening of sales and issuances may influence the trading price of the ETNs or cause the premium or discount to decrease or to no longer be present, though it is not possible to predict such impact. In particular, if an investor paid a premium purchase price over the indicative value of the ETNs, it could lead to significant losses in the event an investor sells ETNs at a time when such premium is no longer present in the marketplace or if Barclays Bank redeems the ETNs at its discretion.

The pricing supplement and prospectus relating to each series of ETNs can be found on EDGAR, the SEC website at www.sec.gov, as well as on the product website at the product page for each of the ETNs listed in the tables above at ipathetn.barclays.

An investment in the ETNs involves significant risks and may not be suitable for all investors. The ETNs are riskier than ordinary unsecured debt securities and do not benefit from any principal protection. For more information on risks associated with the ETNs, please see “Selected Risk Considerations” below and the risk factors included in the relevant pricing supplement.

Barclays Bank is the issuer of the ETNs and Barclays Capital Inc. is the issuer’s agent in the distribution. Please contact Barclays Bank for further questions:

  • Financial advisors: Directly contact Barclays Bank at etndesk@barclays.com or 1-212-528-7990 to obtain further information.
  • Individual investors: Instruct your broker/advisor/custodian to email us at etndesk@barclays.com or to call us at: 1-212-528-7990. You may call in together with your broker/advisor/custodian or have them speak to us on your behalf.

About Barclays

Barclays is a British universal bank. We are diversified by business, by different types of customers and clients, and by geography. Our businesses include consumer banking and payments operations around the world, as well as a full-service corporate and investment bank. For further information about Barclays, please visit our website www.barclays.com.

Selected Risk Considerations

An investment in the ETNs described herein involves risks. Selected risks are summarized here, but we urge you to read the more detailed explanation of risks described under “Risk Factors” in the applicable prospectus supplement and pricing supplement.

You May Lose Some or All of Your Principal: The ETNs are exposed to any change in the level of the underlying index between the inception date and the applicable valuation date. Additionally, if the level of the underlying index is insufficient to offset the negative effect of the investor fee and other applicable costs, you will lose some or all of your investment at maturity or upon redemption, even if the value of such index has increased or decreased, as the case may be. Because the ETNs are subject to an investor fee and other applicable costs, the return on the ETNs will always be lower than the total return on a direct investment in the index components. The ETNs are riskier than ordinary unsecured debt securities and have no principal protection.

Credit of Barclays Bank PLC: The ETNs are unsecured debt obligations of Barclays Bank PLC and are not, either directly or indirectly, an obligation of or guaranteed by any third party. Any payment to be made on the ETNs, including any payment at maturity or upon redemption, depends on the ability of Barclays Bank PLC to satisfy its obligations as they come due. As a result, the actual and perceived creditworthiness of Barclays Bank PLC will affect the market value, if any, of the ETNs prior to maturity or redemption. In addition, if Barclays Bank PLC were to default on its obligations, you may not receive any amounts owed to you under the terms of the ETNs.

Issuer Redemption: If specified in the applicable prospectus, Barclays Bank PLC will have the right to redeem or call the ETNs (in whole but not in part) at its sole discretion and without your consent on any trading day on or after the inception date until and including maturity.

Market and Volatility Risk: The market value of the ETNs may be influenced by many unpredictable factors and may fluctuate between the date you purchase them and the maturity date or redemption date. You may also sustain a significant loss if you sell your ETNs in the secondary market. Factors that may influence the market value of the ETNs include prevailing market prices of the commodity markets, the U.S. stock markets or the U.S. Treasury market, the index components included in the underlying index, and prevailing market prices of options on such index or any other financial instruments related to such index; and supply and demand for the ETNs, including economic, financial, political, regulatory, geographical or judicial events that affect the level of such index or other financial instruments related to such index.

A Trading Market for the ETNs May Not Develop: Although the ETNs are listed on a U.S. national securities exchange, a trading market for the ETNs may not develop and the liquidity of the ETNs may be limited, as we are not required to maintain any listing of the ETNs.

No Interest Payments from the ETNs: You may not receive any interest payments on the ETNs.

Restrictions on the Minimum Number of ETNs and Date Restrictions for Redemptions: Except as specified in the pricing supplement, you must redeem at least the minimum number of ETNs specified in the pricing supplement at one time in order to exercise your right to redeem your ETNs on any redemption date. You may only redeem your ETNs on a redemption date if we receive a notice of redemption from you by certain dates and times as set forth in the pricing supplement.

Uncertain Tax Treatment: Significant aspects of the tax treatment of the ETNs are uncertain. You should consult your own tax advisor about your own tax situation.

The ETNs may be sold throughout the day on the exchange through any brokerage account. Commissions may apply and there are tax consequences in the event of sale, redemption or maturity of ETNs. Sales in the secondary market may result in significant losses.

Barclays Bank PLC has filed a registration statement (including a base prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the base prospectus for this offering in that registration statement and other documents Barclays Bank PLC has filed with the SEC for more complete information about Barclays Bank PLC and this offering. You may get these documents for free by searching the SEC online database (EDGAR) at www.sec.gov. Alternatively, you may obtain a copy of the base prospectus from Barclays Bank PLC by calling toll-free 1-888-227-2275 (extension 7-7990).

© 2022 Barclays Bank PLC. All rights reserved. iPath, iPath ETNs and the iPath logo are registered trademarks of Barclays Bank PLC. All other trademarks, servicemarks or registered trademarks are the property, and used with the permission, of their respective owners.

NOT FDIC INSURED · NO BANK GUARANTEE · MAY LOSE VALUE

 


ę Business Wire 2022
All news about BARCLAYS PLC
05:58aBarclays CEO To Work From Home After Starting Cancer Treatment
MT
05:36aBarclays CEO reveals cancer treatment but will continue to manage bank
AN
04:56aBarclays says CEO Venkatakrishnan to undergo cancer treatment
RE
04:55aBarclays says CEO to undergo cancer treatment and to work from home
RE
04:53aBarclays CEO CS Venkatakrishnan Diagnosed with Non-Hodgkin Lymphoma
DJ
04:46aLONDON BROKER RATINGS: UBS cuts Persimmon to 'sell' from 'neutral'
AN
02:51aNESTLE : Barclays gives a Buy rating
MD
02:40aTHYSSENKRUPP : Gets a Sell rating from Barclays
MD
02:39aBRENNTAG : Gets a Neutral rating from Barclays
MD
02:07aBNP PARIBAS : Upgraded to Buy by Barclays
MD
More news
Analyst Recommendations on BARCLAYS PLC
More recommendations
Financials
Sales 2022 25 059 M 30 290 M 30 290 M
Net income 2022 4 978 M 6 017 M 6 017 M
Net Debt 2022 - - -
P/E ratio 2022 5,40x
Yield 2022 4,55%
Capitalization 25 207 M 30 469 M 30 469 M
Capi. / Sales 2022 1,01x
Capi. / Sales 2023 0,97x
Nbr of Employees 81 600
Free-Float 99,7%
Chart BARCLAYS PLC
Duration : Period :
Barclays PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BARCLAYS PLC
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 159,06 GBX
Average target price 230,83 GBX
Spread / Average Target 45,1%
EPS Revisions
Managers and Directors
C. S. Venkatakrishnan Group Chief Executive Officer & Director
Angela Anna Cross Group Finance Director & Executive Director
Nigel Paul Higgins Group Chairman
Mark Ashton Rigby Group Chief Operating Officer
Laura Padovani Global Head-Compliance Services
Sector and Competitors
1st jan.Capi. (M$)
BARCLAYS PLC-14.94%30 469
JPMORGAN CHASE & CO.-13.65%401 086
BANK OF AMERICA CORPORATION-15.26%302 446
INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED-12.50%205 181
WELLS FARGO & COMPANY-1.13%180 770
CHINA CONSTRUCTION BANK CORPORATION-12.96%151 999